Recent Securities Litigations

Verrica Pharmaceuticals Inc. Common Stock (NASDAQ: VRCA)

40 Days left to seek lead plaintiff status.

Company Name:Verrica Pharmaceuticals Inc. Common Stock
Stock Symbol:NASDAQ: VRCA
Class Period Start:05/28/2021
Class Period End (inclusive):05/24/2022
Filing Deadline:08/05/2022

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, the Complaint alleges Defendants failed to disclose to investors: (1) that there were manufacturing deficiencies at the facility where Verrica’s contract manufacturer produced bulk solution for VP-102; (2) that these deficiencies were not remediated when Verrica resubmitted its NDA for VP-102 for molluscum; (3) that the foregoing presented significant risks to Verrica obtaining regulatory approval of VP-102 for molluscum; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Verrica Pharmaceuticals Inc. Common Stock (NASDAQ: VRCA) Claim Form

Name(Required)
Address
Consent(Required)
This field is for validation purposes and should be left unchanged.